Capital Analysts LLC’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62K | Sell |
883
-175
| -17% | -$12.3K | ﹤0.01% | 768 |
|
|
2025
Q1 | $78K | Buy |
1,058
+107
| +11% | +$7.89K | ﹤0.01% | 695 |
|
|
2024
Q4 | $62K | Buy |
951
+21
| +2% | +$1.37K | ﹤0.01% | 707 |
|
|
2024
Q3 | $73K | Buy |
930
+451
| +94% | +$35.4K | ﹤0.01% | 647 |
|
|
2024
Q2 | $38K | Buy |
479
+19
| +4% | +$1.51K | ﹤0.01% | 758 |
|
|
2024
Q1 | $31K | Buy |
460
+84
| +22% | +$5.66K | ﹤0.01% | 751 |
|
|
2023
Q4 | $25K | Hold |
376
| – | – | ﹤0.01% | 775 |
|
|
2023
Q3 | $25K | Buy |
376
+3
| +0.8% | +$199 | ﹤0.01% | 736 |
|
|
2023
Q2 | $27K | Hold |
373
| – | – | ﹤0.01% | 678 |
|
|
2023
Q1 | $26K | Buy |
373
+5
| +1% | +$349 | ﹤0.01% | 684 |
|
|
2022
Q4 | $25K | Sell |
368
-101
| -22% | -$6.86K | ﹤0.01% | 717 |
|
|
2022
Q3 | $26K | Buy |
469
+208
| +80% | +$11.5K | ﹤0.01% | 678 |
|
|
2022
Q2 | $17K | Hold |
261
| – | – | ﹤0.01% | 721 |
|
|
2022
Q1 | $17K | Buy |
261
+4
| +2% | +$261 | ﹤0.01% | 687 |
|
|
2021
Q4 | $15K | Hold |
257
| – | – | ﹤0.01% | 758 |
|
|
2021
Q3 | $15K | Sell |
257
-42
| -14% | -$2.45K | ﹤0.01% | 733 |
|
|
2021
Q2 | $18K | Hold |
299
| – | – | ﹤0.01% | 679 |
|
|
2021
Q1 | $15K | Buy |
299
+255
| +580% | +$12.8K | ﹤0.01% | 741 |
|
|
2020
Q4 | $2K | Buy |
+44
| New | +$2K | ﹤0.01% | 682 |
|
|
2019
Q1 | – | Sell |
-18
| Closed | -$1K | – | 660 |
|
|
2018
Q4 | $1K | Hold |
18
| – | – | ﹤0.01% | 570 |
|
|
2018
Q3 | $1K | Hold |
18
| – | – | ﹤0.01% | 546 |
|
|
2018
Q2 | $1K | Hold |
18
| – | – | ﹤0.01% | 554 |
|
|
2018
Q1 | $1K | Buy |
+18
| New | +$1K | ﹤0.01% | 542 |
|